Intermountain Healthcare announces new CEO

Cara Livernois | | Health Exec | Management

Intermountain Healthcare has announced Dr. A. Marc Harrison as the new president and CEO of the 22-hospital medical group, reports KSL in Salt Lake City.

The new CEO will head Intermountain Healthcare, which employs 1,300 physicians across 22 hospitals and 185 clinics.

"Dr. Harrison has impressive experience and a proven track record of leading health organizations, and is immensely qualified to build on Intermountain’s legacy and oversee the organization as we continue the work of transforming health care to meet the challenges ahead," said Scott Anderson, Board Chairman and CEO of Zions Bank.  

Harrisons latest accomplishments include having experience as chief of international business development for Cleveland Clinic in Ohio, serving as the chief medical operations officer for the as well as chairman of pediatric critical care, and CEO of the Cleveland Clinic in Abu Dhabi, United Arab Emirates.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.